Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew A Tang

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Cell|September 10, 2009
SnapShot: Convenient, comprehensive, and now clickableNathan E Bress, Robert P Kruger, Andrew A Tang
Nature|November 4, 2021
Publisher Correction: A metastasis map of human cancer cell linesXin Jin, Zelalem Demere, Karthik Nair, et al.
Nature|December 10, 2020
A metastasis map of human cancer cell linesXin Jin, Zelalem Demere, Karthik Nair, et al.
Nature Cancer|April 19, 2022
Phosphate dysregulation via the XPR1-KIDINS220 protein complex is a therapeutic vulnerability in ovarian cancerDaniel P Bondeson, Brenton R Paolella, Adhana Asfaw, et al.
Nature Cancer|July 3, 2020
Discovering the anti-cancer potential of non-oncology drugs by systematic viability profilingSteven M Corsello, Rohith T Nagari, Ryan D Spangler, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Cell|September 10, 2009
SnapShot: Convenient, comprehensive, and now clickableNathan E Bress, Robert P Kruger, Andrew A Tang
Nature|November 4, 2021
Publisher Correction: A metastasis map of human cancer cell linesXin Jin, Zelalem Demere, Karthik Nair, et al.
Nature|December 10, 2020
A metastasis map of human cancer cell linesXin Jin, Zelalem Demere, Karthik Nair, et al.
Nature Cancer|April 19, 2022
Phosphate dysregulation via the XPR1-KIDINS220 protein complex is a therapeutic vulnerability in ovarian cancerDaniel P Bondeson, Brenton R Paolella, Adhana Asfaw, et al.
Nature Cancer|July 3, 2020
Discovering the anti-cancer potential of non-oncology drugs by systematic viability profilingSteven M Corsello, Rohith T Nagari, Ryan D Spangler, et al.
Pageof 1